152 related articles for article (PubMed ID: 8986533)
1. Microglandular adenocarcinoma of the endometrium: a form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix.
Zaloudek C; Hayashi GM; Ryan IP; Powell CB; Miller TR
Int J Gynecol Pathol; 1997 Jan; 16(1):52-9. PubMed ID: 8986533
[TBL] [Abstract][Full Text] [Related]
2. Mucinous endometrial adenocarcinoma simulating microglandular hyperplasia of the cervix.
Fukunaga M
Pathol Int; 2000 Jul; 50(7):541-5. PubMed ID: 10886736
[TBL] [Abstract][Full Text] [Related]
3. A case of microglandular adenocarcinoma of the endometrium.
Karateke A; Haliloglu B; Atay V; Gurbuz A; Kir G
Gynecol Oncol; 2005 Dec; 99(3):778-81. PubMed ID: 16229880
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium.
Chekmareva M; Ellenson LH; Pirog EC
Int J Gynecol Pathol; 2008 Oct; 27(4):547-54. PubMed ID: 18753965
[TBL] [Abstract][Full Text] [Related]
5. Mitotically active microglandular hyperplasia of the cervix: a case series with implications for the differential diagnosis.
Abi-Raad R; Alomari A; Hui P; Buza N
Int J Gynecol Pathol; 2014 Sep; 33(5):524-30. PubMed ID: 25083971
[TBL] [Abstract][Full Text] [Related]
6. Microglandular adenocarcinoma of the uterus mimicking microglandular cervical hyperplasia.
Zamecnik M; Skalova A; Opatrny V
Ann Diagn Pathol; 2003 Jun; 7(3):180-6. PubMed ID: 12808571
[TBL] [Abstract][Full Text] [Related]
7. Comparison of morphologic and immunohistochemical features of cervical microglandular hyperplasia with low-grade mucinous adenocarcinoma of the endometrium.
Qiu W; Mittal K
Int J Gynecol Pathol; 2003 Jul; 22(3):261-5. PubMed ID: 12819393
[TBL] [Abstract][Full Text] [Related]
8. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance.
Nucci MR; Prasad CJ; Crum CP; Mutter GL
Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266
[TBL] [Abstract][Full Text] [Related]
9. Low-grade mucinous adenocarcinoma of the uterine corpus: a rare and deceptively bland form of endometrial carcinoma.
Fujiwara M; Longacre TA
Am J Surg Pathol; 2011 Apr; 35(4):537-44. PubMed ID: 21378544
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic application of KRAS mutation testing in uterine microglandular proliferations.
Hong W; Abi-Raad R; Alomari AK; Hui P; Buza N
Hum Pathol; 2015 Jul; 46(7):1000-5. PubMed ID: 25997988
[TBL] [Abstract][Full Text] [Related]
11. Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review.
Liang SX; Patel K; Pearl M; Liu J; Zheng W; Tornos C
Int J Gynecol Pathol; 2007 Jul; 26(3):291-7. PubMed ID: 17581414
[TBL] [Abstract][Full Text] [Related]
12. Microglandular hyperplasia: a pitfall in the diagnosis of microglandular type endometrioid adenocarcinoma.
Da Forno PD; McGregor AH; Brown LJ
Histopathology; 2005 Mar; 46(3):346-8. PubMed ID: 15720424
[No Abstract] [Full Text] [Related]
13. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
Cina SJ; Richardson MS; Austin RM; Kurman RJ
Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
[TBL] [Abstract][Full Text] [Related]
14. Utility of p63 and PTEN staining in distinguishing cervical microglandular hyperplasia from endometrial endometrioid carcinoma with microglandular/mucinous features.
Aoun BA; Skala SL
Histopathology; 2022 Jun; 80(7):1102-1111. PubMed ID: 35347751
[TBL] [Abstract][Full Text] [Related]
15. Problems in the differential diagnosis of endometrial hyperplasia and carcinoma.
Silverberg SG
Mod Pathol; 2000 Mar; 13(3):309-27. PubMed ID: 10757341
[TBL] [Abstract][Full Text] [Related]
16. CD10 immunostaining distinguishes atypical polypoid adenomyofibroma (atypical polypoid adenomyoma) from endometrial carcinoma invading the myometrium.
Ohishi Y; Kaku T; Kobayashi H; Aishima S; Umekita Y; Wake N; Tsuneyoshi M
Hum Pathol; 2008 Oct; 39(10):1446-53. PubMed ID: 18619643
[TBL] [Abstract][Full Text] [Related]
17. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
[TBL] [Abstract][Full Text] [Related]
18. [Microglandular hyperplasia of the cervix: reevaluation of the polyp (author's transl)].
Jobo T; Kuramoto H; Morisawa T
Acta Obstet Gynaecol Jpn; 1981 May; 33(5):651-8. PubMed ID: 7234352
[TBL] [Abstract][Full Text] [Related]
19. PAX2 and cyclin D1 expression in the distinction between cervical microglandular hyperplasia and endometrial microglandular-like carcinoma: a comparison with p16, vimentin, and Ki67.
Stewart CJ; Crook ML
Int J Gynecol Pathol; 2015 Jan; 34(1):90-100. PubMed ID: 25473758
[TBL] [Abstract][Full Text] [Related]
20. 'Minimal deviation' endometrioid carcinoma with oncocytic change of the endometrium.
Mai KT; Yazdi HM; Boone SA
Arch Pathol Lab Med; 1995 Aug; 119(8):751-4. PubMed ID: 7544107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
